<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Haematology</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/29E28B0A-0B19-4075-B4EE-C67C6844C753"><gtr:id>29E28B0A-0B19-4075-B4EE-C67C6844C753</gtr:id><gtr:firstName>James</gtr:firstName><gtr:otherNames>Andrew</gtr:otherNames><gtr:surname>Huntington</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G117%2F444"><gtr:id>706E660F-DEB5-47CB-B7F1-E1EE9544542D</gtr:id><gtr:title>Structural Mechanisms for Inhibition of Coagulation Proteases</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G117/444</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2002-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>686681</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>900000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Senior Non-Clinical Fellowship (renewal)</gtr:description><gtr:end>2011-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0601596</gtr:fundingRef><gtr:id>ECA78984-8B17-4EF1-B049-F38024A7D3CB</gtr:id><gtr:outcomeId>3A84E0BF8E30</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>ApcinteX Ltd</gtr:companyName><gtr:description>ApcinteX is a virtual biopharmaceutical company developing SerpinPC as a novel bypassing agent to treat bleeding disorders.</gtr:description><gtr:id>F3A7896E-FC30-495C-B1BD-ED48C606CF8E</gtr:id><gtr:impact>Seed phase funding was obtained to de-risk asset prior to a full Series A round. &amp;pound;14M Series A round completed 7 December 2016.</gtr:impact><gtr:outcomeId>5464b2f053a1b7.36716424</gtr:outcomeId><gtr:yearCompanyFormed>2014</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>435CD44D-9C7C-4370-91C8-1E7E4D658E59</gtr:id><gtr:title>How serpins change their fold for better and for worse.</gtr:title><gtr:parentPublicationTitle>Biochemical Society symposium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d5ec8736976c53c591f26f42505960c"><gtr:id>1d5ec8736976c53c591f26f42505960c</gtr:id><gtr:otherNames>Carrell RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0067-8694</gtr:issn><gtr:outcomeId>pm_12842_12_14587291</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>970AF743-90C8-4B68-AE77-9217E0E9AAC6</gtr:id><gtr:title>The molecular basis of thrombin allostery revealed by a 1.8 A structure of the &amp;quot;slow&amp;quot; form.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7823177e5f34aa3434ec7d9a3574641e"><gtr:id>7823177e5f34aa3434ec7d9a3574641e</gtr:id><gtr:otherNames>Huntington JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>pm_12842_12_12679024</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D39AEF77-EA85-45DC-82EF-C24CF6D18EF8</gtr:id><gtr:title>Directing thrombin.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9caf3dec0eca657640fd126a77f77f97"><gtr:id>9caf3dec0eca657640fd126a77f77f97</gtr:id><gtr:otherNames>Lane DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_12842_12_15994286</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E831EEC2-C754-4EA9-BFFB-E65ED8717CF4</gtr:id><gtr:title>The heparin binding site of protein C inhibitor is protease-dependent.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce73e661495882f5061c864c6e2c1985"><gtr:id>ce73e661495882f5061c864c6e2c1985</gtr:id><gtr:otherNames>Li W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>D31B18EDED4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC3B7442-E0A8-43FA-955B-5E97FC3BA53D</gtr:id><gtr:title>Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce73e661495882f5061c864c6e2c1985"><gtr:id>ce73e661495882f5061c864c6e2c1985</gtr:id><gtr:otherNames>Li W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>pm_12842_12_15311269</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56459D8C-D6F0-444A-81EC-4009185C2743</gtr:id><gtr:title>Slow thrombin in solution.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7823177e5f34aa3434ec7d9a3574641e"><gtr:id>7823177e5f34aa3434ec7d9a3574641e</gtr:id><gtr:otherNames>Huntington JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_12842_12_16111476</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7391E55B-B58C-4F84-84C2-BE6C8488A437</gtr:id><gtr:title>Chemistry and Biology of Heparin and Heparan Sulfate</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccd0bf9182960d1ccf7cda2c917812d6"><gtr:id>ccd0bf9182960d1ccf7cda2c917812d6</gtr:id><gtr:otherNames>Huntington J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:isbn>978-0-08-044859-6</gtr:isbn><gtr:outcomeId>rjTyGdohanA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23B081C7-A6BD-4014-AEE4-29BFF6DAF3A5</gtr:id><gtr:title>Crystal structure of anticoagulant thrombin variant E217K provides insights into thrombin allostery.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7099652dbd17f42dd9c1ed192ce4df6"><gtr:id>c7099652dbd17f42dd9c1ed192ce4df6</gtr:id><gtr:otherNames>Carter WJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_12842_12_15075325</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC2AF327-CB3D-4B2A-A688-E994D6ABDFF6</gtr:id><gtr:title>Mutations in the shutter region of antithrombin result in formation of disulfide-linked dimers and severe venous thrombosis.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ebc630b44ce9f81a042d1b77ff31787"><gtr:id>2ebc630b44ce9f81a042d1b77ff31787</gtr:id><gtr:otherNames>Corral J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>pm_12842_12_15140129</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7DD6797-830E-4018-877F-6837066DBA5B</gtr:id><gtr:title>Molecular recognition mechanisms of thrombin.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7823177e5f34aa3434ec7d9a3574641e"><gtr:id>7823177e5f34aa3434ec7d9a3574641e</gtr:id><gtr:otherNames>Huntington JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>pm_12842_12_16102053</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E12EAD8-B996-44E8-9B42-4651EB90F729</gtr:id><gtr:title>Crystal structure of wild-type human thrombin in the Na+-free state.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e7c03df186a731bfc5c64a4410e3a0f"><gtr:id>5e7c03df186a731bfc5c64a4410e3a0f</gtr:id><gtr:otherNames>Johnson DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>pm_12842_12_16201969</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B518D569-A5AC-46EE-B830-5F26D9C14196</gtr:id><gtr:title>Crystal structure of monomeric native antithrombin reveals a novel reactive center loop conformation.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e7c03df186a731bfc5c64a4410e3a0f"><gtr:id>5e7c03df186a731bfc5c64a4410e3a0f</gtr:id><gtr:otherNames>Johnson DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>fcWExiL4ho9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1159B0F-6DA1-46EB-BE23-3B248917450A</gtr:id><gtr:title>Thrombin inhibition by the serpins.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7823177e5f34aa3434ec7d9a3574641e"><gtr:id>7823177e5f34aa3434ec7d9a3574641e</gtr:id><gtr:otherNames>Huntington JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>pm_12842_22_23809129</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ACEB0DE8-C689-4B78-9BE8-D9A81EF1A069</gtr:id><gtr:title>Crystal structure of thrombin bound to heparin.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7099652dbd17f42dd9c1ed192ce4df6"><gtr:id>c7099652dbd17f42dd9c1ed192ce4df6</gtr:id><gtr:otherNames>Carter WJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_12842_12_15548541</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD02C411-E99F-4EA9-B879-77DBA1485767</gtr:id><gtr:title>Structural insights into the multiple functions of protein C inhibitor.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7823177e5f34aa3434ec7d9a3574641e"><gtr:id>7823177e5f34aa3434ec7d9a3574641e</gtr:id><gtr:otherNames>Huntington JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn><gtr:outcomeId>D85C4F9F022</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56D00E63-9456-4874-B6C9-31F5114B0300</gtr:id><gtr:title>The influence of hinge region residue Glu-381 on antithrombin allostery and metastability.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e7c03df186a731bfc5c64a4410e3a0f"><gtr:id>5e7c03df186a731bfc5c64a4410e3a0f</gtr:id><gtr:otherNames>Johnson DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_12842_12_14623882</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>821D8B9B-F417-4A5C-8809-1C457D37FF29</gtr:id><gtr:title>Allosteric activation of antithrombin is independent of charge neutralization or reversal in the heparin binding site.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e1dfbf3dfb04d4716db748368a33dbd"><gtr:id>2e1dfbf3dfb04d4716db748368a33dbd</gtr:id><gtr:otherNames>Langdown J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>ZexvpVeTBXZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>133B0E95-BBF1-42C2-9AA8-932A202F94FF</gtr:id><gtr:title>Heparin-induced substrate behavior of antithrombin Cambridge II.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2237ee99f50e89c1d7a014a2158ac892"><gtr:id>2237ee99f50e89c1d7a014a2158ac892</gtr:id><gtr:otherNames>Mushunje A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_12842_12_12907439</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2C37572-B14B-4A78-B1AB-DF8541007257</gtr:id><gtr:title>Serpin structure, function and dysfunction.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7823177e5f34aa3434ec7d9a3574641e"><gtr:id>7823177e5f34aa3434ec7d9a3574641e</gtr:id><gtr:otherNames>Huntington JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>GXtVu5Rg9oW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB322B28-574B-4339-9136-2DBDD3933FE1</gtr:id><gtr:title>Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e7c03df186a731bfc5c64a4410e3a0f"><gtr:id>5e7c03df186a731bfc5c64a4410e3a0f</gtr:id><gtr:otherNames>Johnson DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>fw7joVA3URK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>688C279C-7D5E-47BF-A046-9832E8DC0326</gtr:id><gtr:title>Crystal structure of antithrombin in a heparin-bound intermediate state.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e7c03df186a731bfc5c64a4410e3a0f"><gtr:id>5e7c03df186a731bfc5c64a4410e3a0f</gtr:id><gtr:otherNames>Johnson DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>pm_12842_12_12873131</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09EE7687-2EE5-4817-9082-83B1B167754A</gtr:id><gtr:title>Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e7c03df186a731bfc5c64a4410e3a0f"><gtr:id>5e7c03df186a731bfc5c64a4410e3a0f</gtr:id><gtr:otherNames>Johnson DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>8C869325B98</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1E2B807-EB1F-48A0-B3C8-7D984B0C80A0</gtr:id><gtr:title>Serpins in thrombosis, hemostasis and fibrinolysis.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a57b2388ca356712432d24fcf1ba8ab4"><gtr:id>a57b2388ca356712432d24fcf1ba8ab4</gtr:id><gtr:otherNames>Rau JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>3774501CC3F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA390A26-33B5-469B-8133-1D42484C4893</gtr:id><gtr:title>Shape-shifting serpins--advantages of a mobile mechanism.</gtr:title><gtr:parentPublicationTitle>Trends in biochemical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7823177e5f34aa3434ec7d9a3574641e"><gtr:id>7823177e5f34aa3434ec7d9a3574641e</gtr:id><gtr:otherNames>Huntington JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0968-0004</gtr:issn><gtr:outcomeId>2F7C129FFAA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69F8C9A4-57BF-4198-85CB-374E5A973912</gtr:id><gtr:title>Thrombin-cofactor interactions: structural insights into regulatory mechanisms.</gtr:title><gtr:parentPublicationTitle>Arteriosclerosis, thrombosis, and vascular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9783b6b1bba923ff7b4e32cf046f51a"><gtr:id>e9783b6b1bba923ff7b4e32cf046f51a</gtr:id><gtr:otherNames>Adams TE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1079-5642</gtr:issn><gtr:outcomeId>pm_12842_12_16728654</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B9F5350-C839-40DC-B202-4DDA36CC28BF</gtr:id><gtr:title>Mechanisms of glycosaminoglycan activation of the serpins in hemostasis.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7823177e5f34aa3434ec7d9a3574641e"><gtr:id>7823177e5f34aa3434ec7d9a3574641e</gtr:id><gtr:otherNames>Huntington JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>pm_12842_12_12871289</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1444A7F1-02CB-4321-92E6-5B8FFC20C31D</gtr:id><gtr:title>Thrombin inhibition by serpins disrupts exosite II.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce73e661495882f5061c864c6e2c1985"><gtr:id>ce73e661495882f5061c864c6e2c1985</gtr:id><gtr:otherNames>Li W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>S813jjVtvfL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D82DD3A-A84F-4027-8C73-B4F05331063B</gtr:id><gtr:title>The heparin binding properties of heparin cofactor II suggest an antithrombin-like activation mechanism.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06cd4ae473bed505bb434c9f34f52214"><gtr:id>06cd4ae473bed505bb434c9f34f52214</gtr:id><gtr:otherNames>O'Keeffe D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_12842_12_15371417</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE1FF773-9B75-410D-9644-B1DE865787AB</gtr:id><gtr:title>Structure of native protein C inhibitor provides insight into its multiple functions.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce73e661495882f5061c864c6e2c1985"><gtr:id>ce73e661495882f5061c864c6e2c1985</gtr:id><gtr:otherNames>Li W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>FCB9FBCBE7F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7AF3CD8-8921-4876-977B-8A634A996FF2</gtr:id><gtr:title>Allosteric activation of antithrombin critically depends upon hinge region extension.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e1dfbf3dfb04d4716db748368a33dbd"><gtr:id>2e1dfbf3dfb04d4716db748368a33dbd</gtr:id><gtr:otherNames>Langdown J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_12842_12_15326167</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BB80A15-4590-4E90-A127-00C4A4BD0316</gtr:id><gtr:title>Homozygous deficiency of heparin cofactor II: relevance of P17 glutamate residue in serpins, relationship with conformational diseases, and role in thrombosis.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ebc630b44ce9f81a042d1b77ff31787"><gtr:id>2ebc630b44ce9f81a042d1b77ff31787</gtr:id><gtr:otherNames>Corral J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>pm_12842_12_15337701</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FDEC883-69D4-4C36-8E99-A096081DCD28</gtr:id><gtr:title>Crystal structure of protein C inhibitor provides insights into hormone binding and heparin activation.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7823177e5f34aa3434ec7d9a3574641e"><gtr:id>7823177e5f34aa3434ec7d9a3574641e</gtr:id><gtr:otherNames>Huntington JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>pm_12842_12_12575940</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G117/444</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>939798CA-B6AE-4C12-9DCC-A0F88F84E6F3</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Blood</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>